TriplePoint Venture Growth BDC (NYSE:TPVG) Releases Earnings Results, Misses Estimates By $0.06 EPS

TriplePoint Venture Growth BDC (NYSE:TPVG) issued its quarterly earnings results on Wednesday. The investment management company reported $0.16 earnings per share for the quarter, missing the consensus estimate of $0.22 by ($0.06), Zacks reports. TriplePoint Venture Growth BDC had a return on equity of 10.68% and a net margin of 44.58%. The business had revenue of $20.17 million during the quarter, compared to analysts’ expectations of $22.18 million.

Here are the key takeaways from TriplePoint Venture Growth BDC’s conference call:

• Quarterly earnings and NAV declined: Net investment income fell to $0.16 per share from $0.21, and NAV dropped to $8.32 from $8.67. Management attributed the lower income partly to selling Prodigy and reduced prepayment income; investment losses also weighed on NAV.
• New investment activity picked up after a very light quarter: TPVG funded just $0.7 million in Q3, citing timing and documentation, but reported $57.4 million funded in Q4 to date, alongside $60 million of new commitments and a pipeline exceeding $2 billion. Management said the Q3 lull was not due to weaker deal demand and reaffirmed a typical quarterly funding range of $25 million–$50 million.
• Liquidity improved and leverage fell: TPVG ended Q3 with $168 million of liquidity, while gross leverage declined to 1.18x from 1.26x, helped by the $43.8 million Prodigy sale. The company is also working to refinance $125 million of notes due in February 2027, a key financial priority.
• Legacy portfolio exposures remain a source of credit risk: Management said most watch-list exposures relate to 2020–2022 vintages, and Q3 included $13.6 million of net realized and unrealized losses across debt investments. It said investments originated from 2023 onward are performing well, but that newer performance does not eliminate the risk tied to older credits.
• The advisor extended its income incentive fee waiver through 2027, which management said should support NII and dividend coverage. The $0.23-per-share base distribution remains the current target, though management noted the board reviews the dividend quarterly and it could change.

TriplePoint Venture Growth BDC Trading Down 7.0%

Shares of TriplePoint Venture Growth BDC stock traded down $0.33 on Thursday, hitting $4.34. 724,473 shares of the company traded hands, compared to its average volume of 329,417. The company has a market cap of $176.88 million, a PE ratio of 4.37 and a beta of 1.35. The stock’s 50 day moving average price is $4.81 and its 200-day moving average price is $5.18. TriplePoint Venture Growth BDC has a 52 week low of $4.11 and a 52 week high of $6.95.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on TPVG. Keefe, Bruyette & Woods dropped their price objective on TriplePoint Venture Growth BDC from $5.50 to $5.00 and set a “market perform” rating for the company in a report on Thursday. Piper Sandler reduced their target price on TriplePoint Venture Growth BDC from $5.50 to $5.00 and set a “neutral” rating on the stock in a research note on Monday, July 13th. Finally, Weiss Ratings downgraded TriplePoint Venture Growth BDC from a “hold (c-)” rating to a “sell (d+)” rating in a research report on Thursday, October 8th. Three analysts have rated the stock with a Hold rating and two have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Reduce” and a consensus price target of $5.00.

More TriplePoint Venture Growth BDC News

Here are the key news stories impacting TriplePoint Venture Growth BDC this week:

• Positive Sentiment: TriplePoint extended its incentive-fee waiver through 2027, which may help support earnings available to shareholders. Article: TriplePoint funding outlook and fee waiver
• Neutral Sentiment: Management expects quarterly fundings of $25 million to $50 million going forward, giving investors an indication of anticipated loan deployment. Article: TriplePoint funding outlook and fee waiver
• Negative Sentiment: Third-quarter earnings fell short of estimates: EPS was $0.16 versus $0.22 expected, and revenue was $20.17 million versus $22.18 million expected. EPS was also down from $0.26 a year earlier, signaling weaker results. Article: Q3 earnings and revenue miss estimates
• Negative Sentiment: Keefe, Bruyette & Woods cut its price target from $5.50 to $5.00 and maintained a “market perform” rating. The new target remains above the cited share price, but the reduction reflects a less optimistic outlook. Analyst rating information

Insider Activity at TriplePoint Venture Growth BDC

In other news, CEO James Labe bought 313,865 shares of the stock in a transaction on Friday, September 18th. The stock was acquired at an average cost of $4.71 per share, for a total transaction of $1,478,304.15. Following the acquisition, the chief executive officer owned 2,312,354 shares of the company’s stock, valued at $10,891,187.34. This represents a 15.71% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Sajal Srivastava sold 313,865 shares of the company’s stock in a transaction on Friday, September 18th. The stock was sold at an average price of $4.71, for a total value of $1,478,304.15. Additional details regarding this sale are available in the official SEC disclosure. 1.55% of the stock is owned by corporate insiders.

TriplePoint Venture Growth BDC Company Profile

TriplePoint Venture Growth BDC Corp. is a business development company that provides financing to venture growth-stage companies. The company primarily invests in businesses backed by venture capital or private equity sponsors, with an emphasis on companies that have developed products or services and are seeking capital to support expansion, acquisitions, working capital and other corporate purposes.

Its investment portfolio is focused largely on companies in technology, life sciences and other high-growth industries.